PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for vatiquinone for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback